- Home
- RGNX vs MAGN Comparison
RGNX vs MAGN Comparison
Compare RGNX & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- MAGN
- Stock Information
- Founded
- RGNX 2008
- MAGN 1864
- Country
- RGNX United States
- MAGN United States
- Employees
- RGNX N/A
- MAGN N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- MAGN Paper
- Sector
- RGNX Health Care
- MAGN Basic Materials
- Exchange
- RGNX Nasdaq
- MAGN Nasdaq
- Market Cap
- RGNX 451.1M
- MAGN 422.2M
- IPO Year
- RGNX 2015
- MAGN N/A
- Fundamental
- Price
- RGNX $9.03
- MAGN $11.38
- Analyst Decision
- RGNX Strong Buy
- MAGN Hold
- Analyst Count
- RGNX 8
- MAGN 1
- Target Price
- RGNX $28.50
- MAGN $14.00
- AVG Volume (30 Days)
- RGNX 502.6K
- MAGN 575.7K
- Earning Date
- RGNX 11-05-2025
- MAGN 11-15-2025
- Dividend Yield
- RGNX N/A
- MAGN N/A
- EPS Growth
- RGNX N/A
- MAGN N/A
- EPS
- RGNX N/A
- MAGN N/A
- Revenue
- RGNX $155,782,000.00
- MAGN $2,919,000,000.00
- Revenue This Year
- RGNX $203.27
- MAGN $49.20
- Revenue Next Year
- RGNX $0.58
- MAGN $5.03
- P/E Ratio
- RGNX N/A
- MAGN N/A
- Revenue Growth
- RGNX 74.95
- MAGN 34.21
- 52 Week Low
- RGNX $5.04
- MAGN $10.39
- 52 Week High
- RGNX $13.48
- MAGN $26.78
- Technical
- Relative Strength Index (RSI)
- RGNX 49.37
- MAGN 41.14
- Support Level
- RGNX $8.82
- MAGN $10.84
- Resistance Level
- RGNX $10.08
- MAGN $11.80
- Average True Range (ATR)
- RGNX 0.54
- MAGN 0.45
- MACD
- RGNX -0.05
- MAGN -0.08
- Stochastic Oscillator
- RGNX 25.27
- MAGN 29.83
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About MAGN Magnera Corporation Common Stock
Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.